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ABSTRACT 
 
Introduction: Maternal mortality is not only a health disadvantage, rather it is a social disadvantage as it puts 
economic burden on the family, community, governments, and nations. Aim: It is prospective study of eclampsia for 
period of 9 months admitted in tertiary care center for treatment. Materials and Methods: 152 cases of eclampsia 
are analysed as to the antenatal care, severity of HTN, type of eclampsia, gestational age, mode of induction, mode 
of delivery, complications, maternal and perinatal outcome with an aim to revise and improvise existing protocols. 
Results: Total deliveries were 12406and incidence in present study is 1.2%, Age of the women is from 20-36 years 
in which Primi’s were 59.2%, Gestational age is more than 28 weeks in 89% of total incidence  mild PIH in 45.8%. 
Perinatal mortality rate 28.3% which is much lower when compared with patients who delivered vaginally 
(43.3%)Vaginal delivery were more than  LSCS , Abortions were 11.8%, 18 cases were found  with IUD 4 maternal 
deaths,2 cases severe HTN & CVA,1 Aspiration pneumonitis,1 pulmonary embolism. Conclusion: Eclampsia a life 
endangering obstetric emergency. Wide awareness of protocols at referal centres, early treatment  and timely referral 
of pre-eclampsia, availability of MICU and NICU facilities will further improve maternal and foetal outcome.  
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Introduction
Eclampsia is defined as development of grand mal 
seizures in women with preeclampsia. Term eclampsia 
is derived from greek word a flash of lightening.80% 
cases of eclampsia is preceded by severe preeclampsia. 
Eclampsia is most severe and life threatening 
manifestation with an estimated risk of 4-5/10,000 live 
births [1]. It rarely may arise in women with minimally 
increased blood pressure and no proteinuria. There is 
significant risk of cardiorespiratory arrest during and 
after seizure. The FOGSI-ICOG National Eclampsia 
Registry (NER) reveals eclampsia prevalence among 
registry as 1.9%.This is 111.725 deliveries analysed  
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and reported by 175 reporting centres. In NER 76.78% 
were antepartum, 9.5% intrapartum and 13.72% were 
postpartum [2].Maternal mortality is very high in 
eclampsia in India about 2-30% depending upon 
severity of complications and type of eclampsia. 
Perinatal mortality is also very high to extent of 30-
50% depending on gestational age, IUGR and mode of 
delivery [3]. Eclampsia is most common in young 
primigravida..The various life threatening 
complications in mother seen include intracranial 
haemorrhages, abruption, aspiration, pulmonary 
edema, acute renal failure and DIC. Although 
eclampsia remains a cause of maternal and foetal 
morbidity and mortality in developed countries, the 
incidence has fallen considerably in developed 
countries due to high quality antenatal care [4,5]. 
However, this decline is not yet observed in developing 
countries [6,7 ]. 
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Materials and methods 
 
This is prospective study of 152 cases of eclampsia 
admitted at MGMH petlaburz, Osmania Medical 
College, Hyderabad of Telangana state, a 460 bedded 
hospital. During the period of 9 months from January 
2014 to September 2014, among 12,406 deliveries 152 
cases of eclampsia were registered. Our incidence of 
eclampsia is 1.2%.  
Inclusion Criteria: 
All patients with diagnosis of eclampsia. 
Exclusion Criteria: 
Patients of epilepsy and other causes os seizures 
i.e;head injury,meningitis,cerebral malaria.Detailed 
history was taken from all these cases at the time of 
admission regarding age, socioeconomic status, parity, 
gestational age, time of onset, number of convulsions, 
duration of convulsions as per proforma. Thorough 
clinical and obstetric examination was done, 
neurological status assessed, bladder catheterized, 
bedside tests (Blood pressure, Clotting time, knee 
jerks, urine output and urine albumin),laboratory 
investigations done which include complete blood 
picture, complete urine examination, coagulation 
profile, Lactate dehydrogenase levels, Liver function 
tests, Blood sugars, Renal function tests, Serum uric 
acid levels, Viral markers, Obstetric scan and Doppler 
studies, CT scan &MRI  in some cases.Control of 
convulsions were done by Pritchard MgSO4 regime 
which was continued for 24 hours after delivery. Alpha 
methyl dopa, labetolol and Nifedipine were used as 
antihypertensives. After stabilizing the patient 
termination of pregnancy was planned according to 
clinical findings for vaginal or caesarean birth. 
Maternal and fetal outcomes were assessed. 
 
Results 
 
Total 12,406 deliveries 152 cases of eclampsia were registered. Our incidence of eclampsia is 1.2% ie 152 cases. 
 
Table 1: Demographic distribution of patients (n =152) 
 
Age  No.of cases Percentages 
<20  years 56 36.8% 
21-25 years 62 40.7% 
26-30 years 28 18.4% 
31-35 years 06 3.94% 
Antenatal care: 
Booked  35 23.1% 
Unbooked 117 76.9% 
Parity  
Primigravida 90 59.2% 
G2 34 22.3% 
G3 16 10.5% 
G4 12 7.8% 
 
77% of cases were less than 25 years of age. 76.9% of cases  were unbooked and referred from peripheral 
centres.55.2% were referrals. Majority of cases were primigravidae(90). 
 
Table 2: Type of Eclampsia, Gestational age, Number of convulsions in present study 
 
Type of Eclampsia No of cases. Percentages. 
Antepartum 126 82.8% 
Intrapartum 14 9.2% 
Postpartum 12 7.8% 
Gestational age 
<28weeks 17 11.1% 
28-32 weeks 42 27.6% 
33-36 weeks 58 38.1% 
>36 weeks 35 23.02% 
Number of convulsions 
1-2 40 26.3% 
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3-4 74 48.6% 
5-6 30 19.7% 
>6 8 5.2% 
Regimen 
Pritchard MgSO4 regimen 132 86.8% 
Phenytoin 10 6.5% 
Diazepam with MgSO4                              14 9.2% 
82.8% convulsions were antepartum. Majority of 
convulsions were in gestational age of 33-36 weeks. 
50% of patients had 3-4 convulsions at admission. 
Maternal mortality was maximum in those patients 
with more number of convulsions. We follow Pritchard 
MgSO4 regimen in our hospital (86.8%) 
 
 
Table 3: Mode of Delivery and Mode of induction in study 
 
Mode of Delivery No. of patients Percentage 
Vaginal Delivery 104 68.4 
LSCS 46 30.2 
Mode of induction 
Misoprostol 38 41.3 
Emecredil 18 19.5 
ARM with oxytocin 30 32.6 
ARM 12 13.04 
 68.4% delivered vaginally, 30.2% delivered by LSCS, 2 patients died undelivered. Majority of patients were 
induced with misoprostol / ARM with oxytocin. 
 
 
Table 4: Clinical outcome, Maternal and Perinatal complications 
 
Clinical outcome Number of cases 
Vaginal delivery 104 cases 
LSCS 46 cases 
Died undelivered 2 cases 
Came with IUD 18 cases 
Maternal death 4 cases 
Maternal Complications  
Abruptio placenta 8, vaginal(3), LSCS(5) 
PPH 10, vaginal(8), LSCS(2) 
Anemia 22 
DIC 10 
HELLP Syndrome 12 
Raised Renal Parameters 8 
Postpartum Psychosis 10 
Pyrexia 4 
Recurrent Convulsions 8 
Transfusion Of Blood 10 
Transfusion Of FFP 12 
Transfusion Of PRP 12 
Blurring Of Vision 6 
PRES Syndrome 4 
DVT 2 
Perinatal complications 
IUGR and Oligohydramnios 20 
Meconium Stained Liquor 15 
IUD 18 
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Still Births 24 
Neonatal Deaths 9 
Preterm Births 115 
NICU Admissions 108 
 
All cases divided into 2 groups based on mode of delivery 104/152 69.3% delivered vaginally, 30.6% (46/152) 
delivered by LSCS, 18 cases came with IUD among them 12 delivered vaginally, 6 patients underwent LSCS. 
Among 4 maternal deaths 2 patients died undelivered with severe hypertension and CVA, 1patient died on first post 
operative day with recurrent convulsions and aspiration pneumonitis another patient died with pulmonary embolism. 
All patients were unbooked young primigravidae and they were late referrals. 
 
Table 5: Perinatal outcome in Vaginal delivery 
 
Birth Weight Total 
births(104) 
Live births(68) Came with 
IUD(12) 
Still births(24) Neonatal 
deaths(9) 
Perinatal outcome  in Vaginal delivery 
<1KG 16 2 NIL 14 NIL 
1-1.5KG 10 8 NIL 2 4 
1.6-2KG 20 12 2 6 3 
2.1-2.5KG 40 32 6 2 2 
2.6-3KG 12 8 4 NIL NIL 
>3KG 6 6 NIL NIL NIL 
Perinatal outcome in LSCS group 
<1KG 4 1 NIL 3 NIL 
1-1.5KG 6 5 NIL 1 NIL 
1.6-2KG 14 7 4 3 NIL 
2.1-2.5KG 14 12 2 NIL NIL 
2.6-3KG 8 8 NIL NIL NIL 
>3KG NIL NIL NIL NIL NIL 
 
 
Total live births 59 out of 104 VD, High perinatal mortality rate of 43.3% in vaginal group. Total live births 33 out 
of 46 LSCS, Perinatal mortality rate 28.3% which is much lower when compared with patients who delivered 
vaginally (43.3%). Early resort to LSCS will significantly improve perinatal outcome. 
 
Discussion 
 
Eclampsia is a life threatening obstetric emergency 
prevalent in developing countries due to inadequate 
antenatal care, low socioeconomic status with lack of 
transport facilities.Eclampsia is more commonly seen 
in young primigravidae. In the present study, eclampsia 
is more commonly seen in primigravidae in age group 
of 21-25 years with 90 cases while in less than 20 years 
of age group there are 56 cases. Maximum number of 
cases were unbooked with 117 cases and majority of 
cases (55.2%) were referred from peripheral health 
care centres, reflecting lack of adequate antenatal care, 
lack of proper health care facilities in peripheries and 
lack of proper transport facilities to tertiary care 
centre.35 booked cases which have developed 
eclampsia might reflect unpredictable nature and 
atypical eclampsia which develops in women with 
nearly normal blood pressure with no or minimal signs 
of eclampsia. Eclampsia is most common in third 
trimester. In our study maximum number of cases were 
seen in the gestational age of 33-36 weeks i.e;58 cases 
followed by 42 cases in 28-32 weeks and 35 cases in 
term patients similar to study done by Sunita et al.8 
Majority of cases(126) were seen in antepartum period 
supporting the dictum that termination is the treatment 
of eclampsia. This is supported by study of Edgar M 
Ndabine et al [9]. 12 cases developed convulsions in 
postpartum period in our study. Pathogenesis of 
postpartum eclampsia is expected due to release of 
FDP after separation of placenta during postpartum 
period. MAGPIE TRIAL (MgSO4 for prevention of 
eclampsia) Collaborative group 2002 administered and 
compared prophylactic MgSO4 with placebo in 10000 
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women. Women who were given mgso4 had 58% 
significant lower risk of eclampsia than with placebo. 
Hence ACOG 2002a, taskforce 2013 recommends 
prophylactic mgso4 should be given in all cases of 
severe pre-eclampsia. It has been established that good 
antenatal care and prophylactic MgSO4 and prompt 
timely delivery prevents eclampsia.  
 
 
Table 6: Comparative Studies 
 
STUDY No Of Patients PNMR MMR 
Pritchard[10] 245 10% 0.4% 
Sibai[11] 254 5% 0.5% 
Ecclampsia And 
Collobarative Study 
Group[12] 
841 24.8% 3.8% 
GMH Study[8] 240 28.3% 3.2% 
Present Study At 
MGMH 
Hyderabad(2014) 
152 25% 2.6%  
PNMR- perinatal mortality rate: MMR-Maternal mortality rate 
  
The definitive treatment of eclampsia is delivery 
irrespective of gestational age to reduce the risk of 
maternal mortality and morbidity. Once eclampsia 
develops there is no role of expectant management. 
Sibai and Barton [13]reviewed recently that expectant 
management may lead to severe maternal 
complications.Mode of delivery was decided by taking 
into consideration several factors like gestational age, 
bishop score, condition of fetus, whether patient is in 
labour. In this study 104 cases were delivered vaginally 
which is also the preferable mode of delivery taking 
into consideration poor status of mother and increased 
risk of morbidity if subjected to surgery.46 cases were 
delivered by caesarean section, 2 patients died 
undelivered thus making rate of caesarean 30.0% 
which is comparatively low as compared to other 
studies by Sunita et al [8] and Edgar M Ndabine et al 
[9]Eclampsia leads to number of life threatening 
complications some of which give very little time for 
obstetricians to act. In our study 8 cases had abruption 
placentae, 10 cases had PPH, 12 cases developed 
HELLP syndrome, 10 cases had DIC,8 cases had acute 
kidney injury,4 cases had PRES syndrome. There were 
4 maternal deaths. Perinatal mortality mainly depends 
on gestational age, birth weight, IUGR, prematurity, 
birth asphyxia. In our study perinatal mortality rate was 
43.3% in vaginal delivery group as compared to 
caesarean group which has perinatal mortality rate of 
28.3% which is comparable to other studies. Majority 
of cases will be referred to tertiary care centre very late 
affecting the perinatal outcome and also maternal 
mortality and near miss. Strengthening the PHCs and 
subcentres with adequate facilities to identify the high 
risk cases and early management of unpredictable cases 
might prove to be beneficial in reducing the perinatal 
and maternal mortality associated with this deadly 
disease.   Strengthening of the peripheries by BEmoNC 
AND CEmoNC TRAINING is recommended. Our 108 
Ambulance services are effective in reducing the 
second delay of maternal mortality.  
 
Conclusion 
 
As most of cases of eclampsia is preceded by severe 
pre-eclampsia, majority of cases might be prevented by 
proper antenatal care, timely identification of signs and 
symptoms of eclampsia, proper training of staff 
especially in peripheral centres so that they can 
recognize high risk cases and refer them to tertiary care 
centre which is equipped to deal with complications 
associated with eclampsia.MgSO4 is the drug of choice 
in preventing and controlling convulsions. Early 
termination of pregnancy improves maternal and 
perinatal outcome. Neonatal salvagability is better by 
early resort to LSCS. There is no increased incidence 
of PPH after giving Magnesium therapy. Our maternal 
mortality rate is 2.6% which is comparable with other 
studies. Strengthening of the tertiary care centres with 
MICU and NICU facilities, better equipped HDU with 
good ventilator support, dialysis for renal failure and 
facilities for availability of blood and blood 
components are essential for better outcome of 
eclampsia patients.    
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